Correlation Between Quality of Life (QoL) of Patients Treated With Nivolumab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck (R/M SCCHN) and Their Caregivers
Idioma
EN
Communication dans un congrès
Este ítem está publicado en
Value in Health, ISPOR Europe 2023, 2023-11-12, Copenhague. 2023-12-01, vol. 26, n° 12 suppl., p. S474
Elsevier BV